TD Cowen analyst Tara Bancroft lowered the firm’s price target on Geron (GERN) to $3 from $4 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GERN:
- Geron: Tempered 2026 Outlook with Execution Risks and Operational Offsets Supports Hold Rating
- Balancing Softer Near-Term Guidance with Capital Discipline and Pipeline Catalysts: Why Geron Merits a Buy Rating and $4 Target
- Geron Issues 2026 Guidance Emphasizing RYTELO Growth
- Geron sees FY26 RYTELO product revenue $220M-$240M
- Geron Amends Term Loan Facility to Extend Draw Deadlines